Novartis | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Bausch Health Companies USD 10.49B 6M 2024-09
Biogen USD 100K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Canopy Growth CAD 8.67B 179.82M 2024-12
Corcept Therapeutics USD 136K 1000 2024-12
Drreddys Laboratories INR 834M 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Indivior 65M 2M 2024-09
J&J USD 3.12B 0 2024-12
Merck USD 1.79B 0 2024-12
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pacira USD 47K 0 2024-12
Perrigo USD 6.73B 30M 2024-12
Pfizer USD 480M 0 2024-12
Prestige Brands USD 559K 2K 2024-12
Roche Holding CHF 107M 0 2024-06
Supernus Pharmaceuticals USD 56K 1000 2024-12
Zoetis USD 5M 0 2024-12



Novartis Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.